Company / Working Capital per Share
Catalyst Pharmaceuticals Partners, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.10
FY2025
5-year range
$1.34 / $6.10
FY2021-FY2025
Trend
+46.5%
vs FY2024
Sector context
#88 of 210
Health Care
What the data says
At $6.10, Catalyst Pharmaceuticals Partners, Inc.'s working capital per share ranks #88 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $0.45 in FY2018 to $6.10 in FY2025.
Based on SEC 10-K filings.
6.10 in FY2025 with a 5-year CAGR of +35.8%.
Improved from $1.34 to $6.10 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +34.6%
- 5-Year CAGR
- +35.8%
- 10-Year CAGR
- -
Sector benchmark
#88 of 210 in Health CareTop 42% of 210This company $6.10 Sector average $146.71
▼
-95.8% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 46.5% year-over-year.
- Ranks #88 out of 210 companies in the Health Care sector.
- Lowest working capital per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.10 | +46.5% |
| FY2024 | $4.16 | +211.1% |
| FY2023 | $1.34 | -46.5% |
| FY2022 | $2.50 | +40.7% |
| FY2021 | $1.78 | +34.6% |
| FY2020 | $1.32 | +55.4% |
| FY2019 | $0.85 | +90.7% |
| FY2018 | $0.45 | -54.3% |
| FY2017 | $0.98 | +105.6% |
| FY2016 | $0.47 | -30.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026